Trial intelligence / Profile preview

Oral vs IV Sodium Chloride for Contrast Nephropathy Prevention

NCT03476460Phase 2Completed

Sponsor
Ramón y Cajal University Hospital
Start
Apr 2014
Primary completion
Nov 2019
Countries
1
01

Overview

A Phase 2 trial of sodium chloride in contrast-induced nephropathy (CIN), sponsored by Ramón y Cajal University Hospital. Started Apr 2014; status: completed.

02

Drugs

sodium chloride
03

Conditions

contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on NCT03476460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03476460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call